Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Obesity and Metabolic Disturbance in Clozapine-Treated Patients
NCT01654640Phase 4Terminated
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2012
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in obesity and metabolic disorder comparing Metformin group with Placebo group (2 arms). Primary endpoint: change of weight at 24 weeks. Started Sep 2012; status: terminated.
02
Drugs
metformin
03
Conditions
obesitymetabolic disorder
Beyond the preview
Go deeper on NCT01654640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01654640.